Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
cancer
3
×
clinical trials
life sciences
national blog main
san francisco blog main
cancer drugs
eli lilly
european society for medical oncology
fda
investing
mirati therapeutics
national top stories
san francisco top stories
89bio
abbvie
adrian krainer
alexion pharmaceuticals
alzheimer europe conference
alzheimer's disease
amgen
astrazeneca
bain capital
biogen
biotech ipos
black diamond therapeutics
bladder cancer
blueprint medicines
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer immunotherapy
cerevel therapeutics
cobimetinib
convergence pharmaceuticals
crispr therapeutics
cystic fibrosis
deals
What
drug
3
×
research
3
×
biotech
cancer
ipo
medicines
targets
alzheimer’s
annual
assessed
attention
bio
black
clinic
communities
companies
conference
despite
diamond
eluded
esmo
europe
family
germany
hardest
hit
hopes
hosted
hottest
hunters
investment
lead
leading
lines
molecular
munich
nears
new
phase
prices
Language
unset
Current search:
cancer
×
drug
×
research
×
biotech
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More